Carrie Rebecca Muh

Carrie Rebecca Muh

Adjunct Assistant Professor in the Department of Neurosurgery

Carrie R. Muh is a Pediatric Neurosurgeon specializing in the surgical treatment of epilepsy. She worked full time at Duke University from 2011 to 2019 and became Adjunct faculty when she moved to New York Medical College in 2019. 
Dr. Muh grew up in California and began scientific research in high school as part of the NASA Student Space Biology initiative. She went on to study at the Massachusetts Institute of Technology (MIT) where she earned two Bachelor's degrees, in Biology and Political Science. During her undergraduate studies, she worked in the laboratory of DNA-repair scientist Dr. Graham Walker. Dr. Muh also earned a Master's degree in Political Science with a concentration in health policy. After graduation, she spent 8 months working on liver cancer research at the Shanghai Cancer Institute in Shanghai, China, returning to attend medical school at Columbia University's College of Physicians and Surgeons. While at Columbia, Dr. Muh spent a year working in the Gabriel Bartoli Brain Tumor laboratory run by Dr. Jeffrey Bruce, and she taught the medical student neuroanatomy review course to the more junior medical students.
Dr. Muh did her neurosurgery residency at Emory University Hospital and her fellowship in Pediatric neurosurgery at Emory/Children's Healthcare of Atlanta (CHOA). During her residency, she spent time in the pediatric brain tumor laboratory of Dr. Donald Durden. She started at Duke as an Assistant Professor in Neurosurgery and Pediatrics in the summer of 2011 after finishing her fellowship. While at Duke full time, she was the director of education for the medical students within the Department of Neurosurgery, directing the medical student sub-internships. She also earned a Master of Health Sciences in Clinical Research degree from Duke University, and graduated from the esteemed Pediatrics Leadership Program at Harvard Medical School. 

Dr. Muh treats all types of pediatric neurological disorders, including brain and spinal cord tumors, moya moya, craniosynostosis, Chiari malformation, spina bifida and hydrocephalus, though she specializes in and is most well-known for pediatric epilepsy surgery. She has done research and published widely on cortical mapping of the brain in patients with epilepsy and on the use of neurostimulators in pediatric patients with epilepsy. 
Dr. Muh also studies new techniques for the treatment of hydrocephalus and noninvasive measurement of intracranial pressure (ICP). She won a Coulter Grant to work with collaborators in the Department of Biomedical Engineering to create a SmartShunt, a CSF-shunt which permits noninvasive measurement of intracranial pressure; a device for which they have been awarded a patent. Dr. Muh was also a team leader on Bass Connections grants to investigate the use of oculomotor assessments to noninvasively diagnose sports-related traumatic brain injury (TBI). She has more than 75 published papers, reviews, commentaries and chapters. 
Since moving to NY in 2019, Dr. Muh has maintained an Adjunct status at Duke to facilitate continued research projects with colleagues here. 

She is now the Chief of Pediatric Neurosurgery and the Surgical Director of the Epilepsy Program at Westchester Medical Center and Maria Fareri Children's Hospital in New York, as well as an Associate Professor of Neurosurgery and Pediatrics at New York Medical College. She is internationally recognized for her work in pediatric epilepsy surgery. She has been invited to speak internationally multiple times and serves on numerous boards including the Executive Committee of the American Association of Neurological Surgeons/Congress of Neurological Surgeons (AANS/CNS) Pediatrics Section. She is on the Board of Directors for the New York Society of Neurosurgery, she serves on the International League Against Epilepsy (ILAE) Epilepsy Surgery Education Taskforce, and she is a member of the International Epilepsy Surgery Society. 

Appointments and Affiliations

  • Adjunct Assistant Professor in the Department of Neurosurgery

Contact Information

  • Office Location: 4544 Hospital South, Box 3272, Durham, NC 27710
  • Office Phone: +1 919 681 2867
  • Email Address:


  • Emory University, School of Medicine, 2011
  • Emory University, School of Medicine, 2010
  • Emory University, School of Medicine, 2004
  • M.D. Columbia University, 2003

Courses Taught

  • NEUROSUR 402C: Intermediate Clinical Neurosurgery

Representative Publications

  • Beaudreault, CP; Muh, CR; Naftchi, A; Spirollari, E; Das, A; Vazquez, S; Sukul, VV; Overby, PJ; Tobias, ME; McGoldrick, PE; Wolf, SM, Responsive Neurostimulation Targeting the Anterior, Centromedian and Pulvinar Thalamic Nuclei and the Detection of Electrographic Seizures in Pediatric and Young Adult Patients., Front Hum Neurosci, vol 16 (2022) [10.3389/fnhum.2022.876204] [abs].
  • Arocho-Quinones, EV; Lew, SM; Handler, MH; Tovar-Spinoza, Z; Smyth, M; Bollo, R; Donahue, D; Perry, MS; Levy, ML; Gonda, D; Mangano, FT; Storm, PB; Price, AV; Couture, DE; Oluigbo, C; Duhaime, A-C; Barnett, GH; Muh, CR; Sather, MD; Fallah, A; Wang, AC; Bhatia, S; Patel, K; Tarima, S; Graber, S; Huckins, S; Hafez, DM; Rumalla, K; Bailey, L; Shandley, S; Roach, A; Alexander, E; Jenkins, W; Tsering, D; Price, G; Meola, A; Evanoff, W; Thompson, EM; Brandmeir, N; Pediatric Stereotactic Laser Ablation Workgroup, , Magnetic resonance-guided stereotactic laser ablation therapy for the treatment of pediatric brain tumors: a multiinstitutional retrospective study., J Neurosurg Pediatr, vol 26 no. 1 (2020), pp. 13-21 [10.3171/2020.1.PEDS19496] [abs].
  • Kim, M; Stein, AA; Overby, P; Kleinman, G; Nuoman, R; Al-Mufti, F; Pisapia, JM; Muh, CR, Pediatric Multi-System Inflammatory Syndrome With Fatal Cerebral Edema in a Patient With COVID-19, NEUROSURGERY, vol 67 (2020), pp. 194-195 [abs].
  • Muh, CR; Chou, ND; Rahimpour, S; Komisarow, JM; Spears, TG; Fuchs, HE; Serafini, S; Grant, GA, Cortical stimulation mapping for localization of visual and auditory language in pediatric epilepsy patients., J Neurosurg Pediatr, vol 25 no. 2 (2019), pp. 168-177 [10.3171/2019.8.PEDS1922] [abs].
  • Sharma, S; Muh, CR; Serafini, S; Chou, ND; Spears, TG; Hodges, SE; Cogan, GB; Komisarow, J; Grant, GA, Multimodality Language Mapping Using Cortical Stimulation in Paediatric Patients With Epilepsy, NEUROSURGERY, vol 66 (2019), pp. 141-141 [abs].
  • Sergesketter, AR; Elsamadicy, AA; Lubkin, DT; Krucoff, KB; Krucoff, MO; Muh, CR, Characterization of Perinatal Risk Factors and Complications Associated With Nonsyndromic Craniosynostosis., J Craniofac Surg, vol 30 no. 2 (2019), pp. 334-338 [10.1097/SCS.0000000000004997] [abs].
  • Hooten, KG; Werner, K; Mikati, MA; Muh, CR, MRI-guided laser interstitial thermal therapy in an infant with tuberous sclerosis: technical case report., J Neurosurg Pediatr, vol 23 no. 1 (2018), pp. 92-97 [10.3171/2018.6.PEDS1828] [abs].
  • Chou, N; Serafini, S; Muh, CR, Cortical Language Areas and Plasticity in Pediatric Patients With Epilepsy: A Review., Pediatr Neurol, vol 78 (2018), pp. 3-12 [10.1016/j.pediatrneurol.2017.10.001] [abs].
  • Krucoff, MO; Chan, AY; Harward, SC; Rahimpour, S; Rolston, JD; Muh, C; Englot, DJ, Rates and predictors of success and failure in repeat epilepsy surgery: A meta-analysis and systematic review., Epilepsia, vol 58 no. 12 (2017), pp. 2133-2142 [10.1111/epi.13920] [abs].
  • Gandolfi, BM; Sobol, DL; Farjat, AE; Allori, AC; Muh, CR; Marcus, JR, Risk Factors for Delayed Referral to a Craniofacial Specialist for Treatment of Craniosynostosis., J Pediatr, vol 186 (2017), pp. 165-171.e2 [10.1016/j.jpeds.2017.03.048] [abs].
  • Chou, ND; Serafini, S; Grant, GA; Clyde, M; Komisarow, J; Muh, CR, 127 Multimodality Word-Finding Distinctions in Pediatric Cortical Stimulation Mapping., Neurosurgery, vol 63 Suppl 1 (2016) [10.1227/01.neu.0000489697.88290.88] [abs].
  • Muh, CR, Current and Emerging Surgical Therapies for Severe Pediatric Epilepsies., Semin Pediatr Neurol, vol 23 no. 2 (2016), pp. 143-150 [10.1016/j.spen.2016.05.005] [abs].
  • Muh, CR; Joshi, S; Singh, AR; Kesari, S; Durden, DL; Makale, MT, PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression., J Neurooncol, vol 116 no. 1 (2014), pp. 89-97 [10.1007/s11060-013-1283-3] [abs].
  • Muh, CR; Oyesiku, NM, Pituitary tumors: Diagnosis and management, Principles of Neurological Surgery (2012), pp. 621-644 [10.1016/B978-1-4377-0701-4.00040-3] [abs].
  • Muh, CR; Ioachimescu, AG; Oyesiku, NM, Growth Hormone-Secreting Tumors, vol 1 (2012), pp. 215-220 [10.1016/B978-1-4160-6839-6.10018-8] [abs].
  • Harris, OA; Muh, CR; Surles, MC; Pan, Y; Rozycki, G; Macleod, J; Easley, K, Discrete cerebral hypothermia in the management of traumatic brain injury: a randomized controlled trial., J Neurosurg, vol 110 no. 6 (2009), pp. 1256-1264 [10.3171/2009.1.JNS081320] [abs].
  • Castellino, RC; Muh, CR; Durden, DL, PI-3 kinase-PTEN signaling node: an intercept point for the control of angiogenesis., Curr Pharm Des, vol 15 no. 4 (2009), pp. 380-388 [10.2174/138161209787315873] [abs].
  • Occhiogrosso, G; Edgar, MA; Sandberg, DI; Souweidane, MM, Prolonged convection-enhanced delivery into the rat brainstem., Neurosurgery, vol 52 no. 2 (2003), pp. 388-393 [10.1227/01.neu.0000043696.83722.8d] [abs].